Category: Haematology

Hemophilia is a lifelong, rare bleeding disorder that affects approximately 1 in 5,000 male births for type A. While a permanent cure for haemophilia remains the ultimate goal, recent medical breakthroughs, particularly in gene therapy, are changing the treatment landscape dramatically.

According to the World Health Organization, anaemia affects one in three women of childbearing age globally, highlighting its widespread nature. Understanding **what are the differential diagnoses of anaemia** is critical for clinicians, as an accurate diagnosis dictates the most effective treatment plan and can uncover serious underlying health issues.

Affecting approximately 1 in 5,000 male births, classical haemophilia, also known as haemophilia A, is a rare genetic bleeding disorder where blood does not clot properly. We’ll explore **what deficiency causes classical haemophilia** and how a specific genetic mutation leads to prolonged bleeding episodes.

Affecting approximately 1 in 5,000 male births, haemophilia is a genetic bleeding disorder where blood doesn't clot properly. Specialised blood tests are essential for diagnosis, and understanding **what is the difference between haemophilia A and B blood results** is crucial for proper treatment and management.